{"transactions":[{"id":779748,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Stock Option","published_at":"2026-05-14T21:54:55.000Z","date":"2026-05-13","kind":"gift","planned":false,"acquired":true,"shares":11728,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 13, 2026, the Reporting Person transferred stock options to a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held in trusts beneficially owned by the Reporting Person, of which the Reporting Person or his family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power."}],"balance_after":99720,"derivative":{"exercise_price":217.5,"exercise_date":"2026-03-15","expiration_date":"2033-03-15","underlying":"Common Stock","underlying_shares":11728},"source":{"system":"sec-edgar","filing":"0001673232-26-000014","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000014/primarydocument.xml","form_type":"4"}},{"id":779747,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Stock Option","published_at":"2026-05-14T21:54:55.000Z","date":"2026-05-13","kind":"gift","planned":false,"acquired":false,"shares":11728,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 13, 2026, the Reporting Person transferred stock options to a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power."}],"balance_after":0,"derivative":{"exercise_price":217.5,"exercise_date":"2026-03-15","expiration_date":"2033-03-15","underlying":"Common Stock","underlying_shares":11728},"source":{"system":"sec-edgar","filing":"0001673232-26-000014","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000014/primarydocument.xml","form_type":"4"}},{"id":839393,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T21:10:36.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":false,"shares":15592,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Shares received upon vesting of performance-based restricted stock units on March 15, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock. These restricted stock units were granted on March 15, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Shares received upon vesting of performance-based restricted stock units on March 15, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock. These restricted stock units were granted on March 15, 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":15592},"source":{"system":"sec-edgar","filing":"0001673232-26-000013","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000013/primarydocument.xml","form_type":"4"}},{"id":839392,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T21:10:36.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":false,"shares":17790,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Shares received upon vesting of performance-based restricted stock units on March 15, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock. These restricted stock units were granted on March 15, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Shares received upon vesting of performance-based restricted stock units on March 15, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock. These restricted stock units were granted on March 15, 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":17790},"source":{"system":"sec-edgar","filing":"0001673232-26-000013","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000013/primarydocument.xml","form_type":"4"}},{"id":839391,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-03-17T21:10:36.000Z","date":"2026-03-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":6869,"price":536.12,"value":3682608.28,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares withheld by United Therapeutics for tax purposes, upon vesting of restricted stock units."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":19046,"source":{"system":"sec-edgar","filing":"0001673232-26-000013","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000013/primarydocument.xml","form_type":"4"}},{"id":839390,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-03-17T21:10:36.000Z","date":"2026-03-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":7837,"price":536.12,"value":4201572.44,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares withheld by United Therapeutics for tax purposes, upon vesting of restricted stock units."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":25915,"source":{"system":"sec-edgar","filing":"0001673232-26-000013","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000013/primarydocument.xml","form_type":"4"}},{"id":839389,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-03-17T21:10:36.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":true,"shares":15592,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":33752,"source":{"system":"sec-edgar","filing":"0001673232-26-000013","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000013/primarydocument.xml","form_type":"4"}},{"id":839388,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-03-17T21:10:36.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":true,"shares":17790,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":17790,"source":{"system":"sec-edgar","filing":"0001673232-26-000013","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000013/primarydocument.xml","form_type":"4"}},{"id":880304,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Restricted Stock Units","published_at":"2026-02-26T21:30:49.000Z","date":"2023-03-15","kind":"grant","planned":false,"acquired":true,"shares":17790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"These performance-based restricted stock units were initially awarded on March 15, 2023, subject to a three-year performance condition tied to clinical development performance during 2023-2025, which was determined on January 20, 2026. The number of restricted stock units reported represents the number of restricted stock units earned based on performance, all of which will vest on March 15, 2026."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Not applicable as restricted stock units do not have an expiration date."}],"balance_after":17790,"derivative":{"exercise_price":0,"exercise_date":"2026-03-15","underlying":"Common Stock","underlying_shares":17790},"source":{"system":"sec-edgar","filing":"0001673232-26-000012","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000012/primarydocument.xml","form_type":"4"}},{"id":880303,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Restricted Stock Units","published_at":"2026-02-26T21:30:49.000Z","date":"2023-03-15","kind":"grant","planned":false,"acquired":true,"shares":15592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"These performance-based restricted stock units were initially awarded on March 15, 2023, subject to a three-year performance condition tied to average revenue growth during 2023-2025, which was determined on February 25, 2026. The number of restricted stock units reported represents the number of restricted stock units earned based on performance, all of which will vest on March 15, 2026."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Not applicable as restricted stock units do not have an expiration date."}],"balance_after":15592,"derivative":{"exercise_price":0,"exercise_date":"2026-03-15","underlying":"Common Stock","underlying_shares":15592},"source":{"system":"sec-edgar","filing":"0001673232-26-000012","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000012/primarydocument.xml","form_type":"4"}},{"id":880302,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Stock Options","published_at":"2026-02-26T21:30:49.000Z","date":"2023-03-15","kind":"grant","planned":false,"acquired":true,"shares":99720,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These performance-based stock options were initially awarded on March 15, 2023, subject to a three-year performance condition tied to average cash profit margin during 2023-2025, which was determined on February 25, 2026. The number of stock options reported represents the number of options earned based on performance, all of which will vest on March 15, 2026."}],"balance_after":99720,"derivative":{"exercise_price":217.5,"exercise_date":"2026-03-15","expiration_date":"2033-03-15","underlying":"Common Stock","underlying_shares":99720},"source":{"system":"sec-edgar","filing":"0001673232-26-000012","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000012/primarydocument.xml","form_type":"4"}},{"id":885910,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-02-24T21:31:32.000Z","date":"2026-02-23","kind":"exercise","planned":true,"acquired":false,"shares":5065,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025. The transactions reported on this Form 4 are the final transactions under this trading plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power."}],"balance_after":0,"derivative":{"exercise_price":146.03,"exercise_date":"2020-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":5065},"source":{"system":"sec-edgar","filing":"0001673232-26-000011","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000011/primarydocument.xml","form_type":"4"}},{"id":885909,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-02-24T21:31:32.000Z","date":"2026-02-23","kind":"exercise","planned":true,"acquired":false,"shares":9375,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025. The transactions reported on this Form 4 are the final transactions under this trading plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":0,"derivative":{"exercise_price":117.76,"exercise_date":"2020-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":9375},"source":{"system":"sec-edgar","filing":"0001673232-26-000011","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000011/primarydocument.xml","form_type":"4"}},{"id":885908,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-02-24T21:31:32.000Z","date":"2026-02-23","kind":"sale","planned":true,"acquired":false,"shares":5065,"price":472.126,"value":2391318.19,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025. The transactions reported on this Form 4 are the final transactions under this trading plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001673232-26-000011","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000011/primarydocument.xml","form_type":"4"}},{"id":885907,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-02-24T21:31:32.000Z","date":"2026-02-23","kind":"exercise","planned":true,"acquired":true,"shares":5065,"price":146.03,"value":739641.95,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025. The transactions reported on this Form 4 are the final transactions under this trading plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power."}],"balance_after":5065,"source":{"system":"sec-edgar","filing":"0001673232-26-000011","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000011/primarydocument.xml","form_type":"4"}},{"id":885906,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-02-24T21:31:32.000Z","date":"2026-02-23","kind":"sale","planned":true,"acquired":false,"shares":9375,"price":472.126,"value":4426181.25,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025. The transactions reported on this Form 4 are the final transactions under this trading plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001673232-26-000011","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000011/primarydocument.xml","form_type":"4"}},{"id":885905,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-02-24T21:31:32.000Z","date":"2026-02-23","kind":"exercise","planned":true,"acquired":true,"shares":9375,"price":117.76,"value":1104000.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025. The transactions reported on this Form 4 are the final transactions under this trading plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":9375,"source":{"system":"sec-edgar","filing":"0001673232-26-000011","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000011/primarydocument.xml","form_type":"4"}},{"id":898226,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-02-18T21:31:00.000Z","date":"2026-02-17","kind":"exercise","planned":true,"acquired":false,"shares":7875,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power."}],"balance_after":5065,"derivative":{"exercise_price":146.03,"exercise_date":"2020-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":7875},"source":{"system":"sec-edgar","filing":"0001673232-26-000010","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000010/primarydocument.xml","form_type":"4"}},{"id":898225,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-02-18T21:31:00.000Z","date":"2026-02-17","kind":"exercise","planned":true,"acquired":false,"shares":14625,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":9375,"derivative":{"exercise_price":117.76,"exercise_date":"2020-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":14625},"source":{"system":"sec-edgar","filing":"0001673232-26-000010","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000010/primarydocument.xml","form_type":"4"}},{"id":898224,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-02-18T21:31:00.000Z","date":"2026-02-17","kind":"sale","planned":true,"acquired":false,"shares":7875,"price":480.7536,"value":3785934.6,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001673232-26-000010","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000010/primarydocument.xml","form_type":"4"}},{"id":898223,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-02-18T21:31:00.000Z","date":"2026-02-17","kind":"exercise","planned":true,"acquired":true,"shares":7875,"price":146.03,"value":1149986.25,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power."}],"balance_after":7875,"source":{"system":"sec-edgar","filing":"0001673232-26-000010","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000010/primarydocument.xml","form_type":"4"}},{"id":898222,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-02-18T21:31:00.000Z","date":"2026-02-17","kind":"sale","planned":true,"acquired":false,"shares":14625,"price":480.7536,"value":7031021.4,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001673232-26-000010","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000010/primarydocument.xml","form_type":"4"}},{"id":898221,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-02-18T21:31:00.000Z","date":"2026-02-17","kind":"exercise","planned":true,"acquired":true,"shares":14625,"price":117.76,"value":1722240.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":14625,"source":{"system":"sec-edgar","filing":"0001673232-26-000010","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000010/primarydocument.xml","form_type":"4"}},{"id":912825,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-02-10T21:30:29.000Z","date":"2026-02-09","kind":"exercise","planned":true,"acquired":false,"shares":7875,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power."}],"balance_after":12940,"derivative":{"exercise_price":146.03,"exercise_date":"2020-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":7875},"source":{"system":"sec-edgar","filing":"0001673232-26-000009","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000009/primarydocument.xml","form_type":"4"}},{"id":912824,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-02-10T21:30:29.000Z","date":"2026-02-09","kind":"exercise","planned":true,"acquired":false,"shares":14625,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":24000,"derivative":{"exercise_price":117.76,"exercise_date":"2020-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":14625},"source":{"system":"sec-edgar","filing":"0001673232-26-000009","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000009/primarydocument.xml","form_type":"4"}},{"id":912823,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-02-10T21:30:29.000Z","date":"2026-02-09","kind":"sale","planned":true,"acquired":false,"shares":7875,"price":474.6527,"value":3737890.0125,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001673232-26-000009","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000009/primarydocument.xml","form_type":"4"}},{"id":912822,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-02-10T21:30:29.000Z","date":"2026-02-09","kind":"exercise","planned":true,"acquired":true,"shares":7875,"price":146.03,"value":1149986.25,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power."}],"balance_after":7875,"source":{"system":"sec-edgar","filing":"0001673232-26-000009","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000009/primarydocument.xml","form_type":"4"}},{"id":912821,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-02-10T21:30:29.000Z","date":"2026-02-09","kind":"sale","planned":true,"acquired":false,"shares":14625,"price":474.6527,"value":6941795.7375,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001673232-26-000009","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000009/primarydocument.xml","form_type":"4"}},{"id":912820,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-02-10T21:30:29.000Z","date":"2026-02-09","kind":"exercise","planned":true,"acquired":true,"shares":14625,"price":117.76,"value":1722240.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":14625,"source":{"system":"sec-edgar","filing":"0001673232-26-000009","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000009/primarydocument.xml","form_type":"4"}},{"id":922801,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Stock Options","published_at":"2026-02-03T21:31:19.000Z","date":"2026-02-02","kind":"exercise","planned":true,"acquired":false,"shares":7875,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power."}],"balance_after":20815,"derivative":{"exercise_price":146.03,"exercise_date":"2020-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":7875},"source":{"system":"sec-edgar","filing":"0001673232-26-000008","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000008/primarydocument.xml","form_type":"4"}},{"id":922800,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Stock Options","published_at":"2026-02-03T21:31:19.000Z","date":"2026-02-02","kind":"exercise","planned":true,"acquired":false,"shares":14625,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":38625,"derivative":{"exercise_price":117.76,"exercise_date":"2020-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":14625},"source":{"system":"sec-edgar","filing":"0001673232-26-000008","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000008/primarydocument.xml","form_type":"4"}},{"id":922799,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-02-03T21:31:19.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":7875,"price":470.9524,"value":3708750.15,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001673232-26-000008","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000008/primarydocument.xml","form_type":"4"}},{"id":922798,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-02-03T21:31:19.000Z","date":"2026-02-02","kind":"exercise","planned":true,"acquired":true,"shares":7875,"price":146.03,"value":1149986.25,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power."}],"balance_after":7875,"source":{"system":"sec-edgar","filing":"0001673232-26-000008","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000008/primarydocument.xml","form_type":"4"}},{"id":922797,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-02-03T21:31:19.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":14625,"price":470.9524,"value":6887678.85,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001673232-26-000008","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000008/primarydocument.xml","form_type":"4"}},{"id":922796,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-02-03T21:31:19.000Z","date":"2026-02-02","kind":"exercise","planned":true,"acquired":true,"shares":14625,"price":117.76,"value":1722240.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":14625,"source":{"system":"sec-edgar","filing":"0001673232-26-000008","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000008/primarydocument.xml","form_type":"4"}},{"id":929269,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Stock Options","published_at":"2026-01-28T21:31:05.000Z","date":"2026-01-26","kind":"exercise","planned":true,"acquired":false,"shares":7875,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power."}],"balance_after":28690,"derivative":{"exercise_price":146.03,"exercise_date":"2020-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":7875},"source":{"system":"sec-edgar","filing":"0001673232-26-000007","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000007/primarydocument.xml","form_type":"4"}},{"id":929268,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Stock Options","published_at":"2026-01-28T21:31:05.000Z","date":"2026-01-26","kind":"exercise","planned":true,"acquired":false,"shares":14625,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F16","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":53250,"derivative":{"exercise_price":117.76,"exercise_date":"2020-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":14625},"source":{"system":"sec-edgar","filing":"0001673232-26-000007","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000007/primarydocument.xml","form_type":"4"}},{"id":929267,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Stock Options","published_at":"2026-01-28T21:31:05.000Z","date":"2026-01-20","kind":"exercise","planned":true,"acquired":false,"shares":7875,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power."}],"balance_after":36565,"derivative":{"exercise_price":146.03,"exercise_date":"2020-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":7875},"source":{"system":"sec-edgar","filing":"0001673232-26-000007","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000007/primarydocument.xml","form_type":"4"}},{"id":929266,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-28T21:31:05.000Z","date":"2026-01-26","kind":"sale","planned":true,"acquired":false,"shares":7875,"price":471.9081,"value":3716276.2875,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001673232-26-000007","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000007/primarydocument.xml","form_type":"4"}},{"id":929265,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-28T21:31:05.000Z","date":"2026-01-26","kind":"exercise","planned":true,"acquired":true,"shares":7875,"price":146.03,"value":1149986.25,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power."}],"balance_after":7875,"source":{"system":"sec-edgar","filing":"0001673232-26-000007","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000007/primarydocument.xml","form_type":"4"}},{"id":929264,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-28T21:31:05.000Z","date":"2026-01-26","kind":"sale","planned":true,"acquired":false,"shares":14625,"price":471.9081,"value":6901655.9625,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F16","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001673232-26-000007","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000007/primarydocument.xml","form_type":"4"}},{"id":929263,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-28T21:31:05.000Z","date":"2026-01-26","kind":"exercise","planned":true,"acquired":true,"shares":14625,"price":117.76,"value":1722240.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F16","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":14625,"source":{"system":"sec-edgar","filing":"0001673232-26-000007","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000007/primarydocument.xml","form_type":"4"}},{"id":929262,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-28T21:31:05.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":14,"price":470.755,"value":6590.57,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001673232-26-000007","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000007/primarydocument.xml","form_type":"4"}},{"id":929261,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-28T21:31:05.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":84,"price":470.37,"value":39511.08,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F15","text":"This transaction was executed in multiple trades at prices ranging from $469.73 to $470.70. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power."}],"balance_after":14,"source":{"system":"sec-edgar","filing":"0001673232-26-000007","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000007/primarydocument.xml","form_type":"4"}},{"id":929260,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-28T21:31:05.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":451,"price":469.1798,"value":211600.0898,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F14","text":"This transaction was executed in multiple trades at prices ranging from $468.73 to $469.65. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power."}],"balance_after":98,"source":{"system":"sec-edgar","filing":"0001673232-26-000007","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000007/primarydocument.xml","form_type":"4"}},{"id":929259,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-28T21:31:05.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":1573,"price":468.1163,"value":736346.9399,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"This transaction was executed in multiple trades at prices ranging from $467.73 to $468.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power."}],"balance_after":549,"source":{"system":"sec-edgar","filing":"0001673232-26-000007","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000007/primarydocument.xml","form_type":"4"}},{"id":929258,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-28T21:31:05.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":321,"price":467.0912,"value":149936.2752,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"This transaction was executed in multiple trades at prices ranging from $466.73 to $467.70. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power."}],"balance_after":2122,"source":{"system":"sec-edgar","filing":"0001673232-26-000007","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000007/primarydocument.xml","form_type":"4"}},{"id":929257,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-28T21:31:05.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":568,"price":466.0631,"value":264723.8408,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"This transaction was executed in multiple trades at prices ranging from $465.62 to $466.57. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power."}],"balance_after":2443,"source":{"system":"sec-edgar","filing":"0001673232-26-000007","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000007/primarydocument.xml","form_type":"4"}},{"id":929256,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-28T21:31:05.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":966,"price":465.1095,"value":449295.777,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"This transaction was executed in multiple trades at prices ranging from $464.62 to $465.615. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power."}],"balance_after":3011,"source":{"system":"sec-edgar","filing":"0001673232-26-000007","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000007/primarydocument.xml","form_type":"4"}},{"id":929255,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-28T21:31:05.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":1225,"price":464.0559,"value":568468.4775,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This transaction was executed in multiple trades at prices ranging from $463.61 to $464.59. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power."}],"balance_after":3977,"source":{"system":"sec-edgar","filing":"0001673232-26-000007","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000007/primarydocument.xml","form_type":"4"}},{"id":929254,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-28T21:31:05.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":1322,"price":463.2604,"value":612430.2488,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $462.61 to $463.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power."}],"balance_after":5202,"source":{"system":"sec-edgar","filing":"0001673232-26-000007","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000007/primarydocument.xml","form_type":"4"}},{"id":929253,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-28T21:31:05.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":271,"price":461.1183,"value":124963.0593,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $460.56 to $461.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power."}],"balance_after":6524,"source":{"system":"sec-edgar","filing":"0001673232-26-000007","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000007/primarydocument.xml","form_type":"4"}},{"id":929252,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-28T21:31:05.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":268,"price":459.8647,"value":123243.7396,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $459.55 to $460.45. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power."}],"balance_after":6795,"source":{"system":"sec-edgar","filing":"0001673232-26-000007","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000007/primarydocument.xml","form_type":"4"}},{"id":929251,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-28T21:31:05.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":377,"price":458.7362,"value":172943.5474,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $458.38 to $459.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power."}],"balance_after":7063,"source":{"system":"sec-edgar","filing":"0001673232-26-000007","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000007/primarydocument.xml","form_type":"4"}},{"id":929250,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-28T21:31:05.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":372,"price":457.918,"value":170345.496,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $457.36 to $458.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power."}],"balance_after":7440,"source":{"system":"sec-edgar","filing":"0001673232-26-000007","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000007/primarydocument.xml","form_type":"4"}},{"id":929249,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-28T21:31:05.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":63,"price":456.8652,"value":28782.5076,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $456.34 to $457.26. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power."}],"balance_after":7812,"source":{"system":"sec-edgar","filing":"0001673232-26-000007","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000007/primarydocument.xml","form_type":"4"}},{"id":929248,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-28T21:31:05.000Z","date":"2026-01-20","kind":"exercise","planned":true,"acquired":true,"shares":7875,"price":146.03,"value":1149986.25,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power."}],"balance_after":7875,"source":{"system":"sec-edgar","filing":"0001673232-26-000007","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000007/primarydocument.xml","form_type":"4"}},{"id":929247,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-28T21:30:31.000Z","date":"2026-01-20","kind":"exercise","planned":true,"acquired":false,"shares":14625,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":67875,"derivative":{"exercise_price":146.03,"exercise_date":"2020-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":14625},"source":{"system":"sec-edgar","filing":"0001673232-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000006/primarydocument.xml","form_type":"4"}},{"id":929246,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-28T21:30:31.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":26,"price":470.755,"value":12239.63,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001673232-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000006/primarydocument.xml","form_type":"4"}},{"id":929245,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-28T21:30:31.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":156,"price":470.37,"value":73377.72,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F15","text":"This transaction was executed in multiple trades at prices ranging from $469.73 to $470.70. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":26,"source":{"system":"sec-edgar","filing":"0001673232-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000006/primarydocument.xml","form_type":"4"}},{"id":929244,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-28T21:30:31.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":837,"price":469.1805,"value":392704.0785,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F14","text":"This transaction was executed in multiple trades at prices ranging from $468.73 to $469.65. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":182,"source":{"system":"sec-edgar","filing":"0001673232-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000006/primarydocument.xml","form_type":"4"}},{"id":929243,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-28T21:30:31.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":2922,"price":468.1165,"value":1367836.413,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"This transaction was executed in multiple trades at prices ranging from $467.73 to $468.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":1019,"source":{"system":"sec-edgar","filing":"0001673232-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000006/primarydocument.xml","form_type":"4"}},{"id":929242,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-28T21:30:31.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":596,"price":467.0911,"value":278386.2956,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"This transaction was executed in multiple trades at prices ranging from $466.73 to $467.70. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":3941,"source":{"system":"sec-edgar","filing":"0001673232-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000006/primarydocument.xml","form_type":"4"}},{"id":929241,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-28T21:30:31.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":1055,"price":466.0637,"value":491697.2035,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"This transaction was executed in multiple trades at prices ranging from $465.62 to $466.57. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":4537,"source":{"system":"sec-edgar","filing":"0001673232-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000006/primarydocument.xml","form_type":"4"}},{"id":929240,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-28T21:30:31.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":1794,"price":465.1096,"value":834406.6224,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"This transaction was executed in multiple trades at prices ranging from $464.62 to $465.615. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":5592,"source":{"system":"sec-edgar","filing":"0001673232-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000006/primarydocument.xml","form_type":"4"}},{"id":929239,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-28T21:30:31.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":2274,"price":464.0562,"value":1055263.7988,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This transaction was executed in multiple trades at prices ranging from $463.61 to $464.59. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":7386,"source":{"system":"sec-edgar","filing":"0001673232-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000006/primarydocument.xml","form_type":"4"}},{"id":929238,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-28T21:30:31.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":2456,"price":463.2606,"value":1137768.0336,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $462.61 to $463.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":9660,"source":{"system":"sec-edgar","filing":"0001673232-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000006/primarydocument.xml","form_type":"4"}},{"id":929237,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-28T21:30:31.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":503,"price":461.1188,"value":231942.7564,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $460.56 to $461.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":12116,"source":{"system":"sec-edgar","filing":"0001673232-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000006/primarydocument.xml","form_type":"4"}},{"id":929236,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-28T21:30:31.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":498,"price":459.8651,"value":229012.8198,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $459.55 to $460.45. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":12619,"source":{"system":"sec-edgar","filing":"0001673232-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000006/primarydocument.xml","form_type":"4"}},{"id":929235,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-28T21:30:31.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":700,"price":458.7368,"value":321115.76,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $458.38 to $459.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":13117,"source":{"system":"sec-edgar","filing":"0001673232-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000006/primarydocument.xml","form_type":"4"}},{"id":929234,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-28T21:30:31.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":692,"price":457.9178,"value":316879.1176,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $457.36 to $458.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":13817,"source":{"system":"sec-edgar","filing":"0001673232-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000006/primarydocument.xml","form_type":"4"}},{"id":929233,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-28T21:30:31.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":116,"price":456.8663,"value":52996.4908,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $456.34 to $457.26. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":14509,"source":{"system":"sec-edgar","filing":"0001673232-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000006/primarydocument.xml","form_type":"4"}},{"id":929232,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-28T21:30:31.000Z","date":"2026-01-20","kind":"exercise","planned":true,"acquired":false,"shares":14625,"price":117.76,"value":1722240.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":14625,"source":{"system":"sec-edgar","filing":"0001673232-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000006/primarydocument.xml","form_type":"4"}},{"id":940343,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Stock Options","published_at":"2026-01-13T22:10:56.000Z","date":"2026-01-12","kind":"exercise","planned":true,"acquired":false,"shares":7875,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power."}],"balance_after":44440,"derivative":{"exercise_price":146.03,"exercise_date":"2020-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":7875},"source":{"system":"sec-edgar","filing":"0001673232-26-000005","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000005/primarydocument.xml","form_type":"4"}},{"id":940342,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Stock Options","published_at":"2026-01-13T22:10:56.000Z","date":"2026-01-12","kind":"exercise","planned":true,"acquired":false,"shares":14625,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":82500,"derivative":{"exercise_price":117.76,"exercise_date":"2020-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":14625},"source":{"system":"sec-edgar","filing":"0001673232-26-000005","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000005/primarydocument.xml","form_type":"4"}},{"id":940341,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-13T22:10:56.000Z","date":"2026-01-12","kind":"sale","planned":true,"acquired":false,"shares":7875,"price":479.5056,"value":3776106.6,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001673232-26-000005","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000005/primarydocument.xml","form_type":"4"}},{"id":940340,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-13T22:10:56.000Z","date":"2026-01-12","kind":"exercise","planned":true,"acquired":true,"shares":7875,"price":146.03,"value":1149986.25,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power."}],"balance_after":7875,"source":{"system":"sec-edgar","filing":"0001673232-26-000005","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000005/primarydocument.xml","form_type":"4"}},{"id":940339,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-13T22:10:56.000Z","date":"2026-01-12","kind":"sale","planned":true,"acquired":false,"shares":14625,"price":479.5056,"value":7012769.4,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001673232-26-000005","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000005/primarydocument.xml","form_type":"4"}},{"id":940338,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-13T22:10:56.000Z","date":"2026-01-12","kind":"exercise","planned":true,"acquired":true,"shares":14625,"price":117.76,"value":1722240.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":14625,"source":{"system":"sec-edgar","filing":"0001673232-26-000005","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000005/primarydocument.xml","form_type":"4"}},{"id":945077,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Stock Options","published_at":"2026-01-07T21:31:02.000Z","date":"2026-01-05","kind":"exercise","planned":true,"acquired":false,"shares":14625,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":97125,"derivative":{"exercise_price":117.76,"exercise_date":"2020-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":14625},"source":{"system":"sec-edgar","filing":"0001673232-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000004/primarydocument.xml","form_type":"4"}},{"id":945076,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-07T21:31:02.000Z","date":"2026-01-05","kind":"sale","planned":true,"acquired":false,"shares":797,"price":494.2723,"value":393935.0231,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F16","text":"This transaction was executed in multiple trades at prices ranging from $493.99 to $494.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001673232-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000004/primarydocument.xml","form_type":"4"}},{"id":945075,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-07T21:31:02.000Z","date":"2026-01-05","kind":"sale","planned":true,"acquired":false,"shares":374,"price":493.4739,"value":184559.2386,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F15","text":"This transaction was executed in multiple trades at prices ranging from $492.96 to $493.88. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":797,"source":{"system":"sec-edgar","filing":"0001673232-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000004/primarydocument.xml","form_type":"4"}},{"id":945074,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-07T21:31:02.000Z","date":"2026-01-05","kind":"sale","planned":true,"acquired":false,"shares":1110,"price":492.4444,"value":546613.284,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F14","text":"This transaction was executed in multiple trades at prices ranging from $491.91 to $492.86. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":1171,"source":{"system":"sec-edgar","filing":"0001673232-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000004/primarydocument.xml","form_type":"4"}},{"id":945073,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-07T21:31:02.000Z","date":"2026-01-05","kind":"sale","planned":true,"acquired":false,"shares":1201,"price":491.3495,"value":590110.7495,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"This transaction was executed in multiple trades at prices ranging from $490.90 to $491.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":2281,"source":{"system":"sec-edgar","filing":"0001673232-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000004/primarydocument.xml","form_type":"4"}},{"id":945072,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-07T21:31:02.000Z","date":"2026-01-05","kind":"sale","planned":true,"acquired":false,"shares":1659,"price":490.1107,"value":813093.6513,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"This transaction was executed in multiple trades at prices ranging from $489.90 to $490.885. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":3482,"source":{"system":"sec-edgar","filing":"0001673232-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000004/primarydocument.xml","form_type":"4"}},{"id":945071,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-07T21:31:02.000Z","date":"2026-01-05","kind":"sale","planned":true,"acquired":false,"shares":677,"price":489.4897,"value":331384.5269,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"This transaction was executed in multiple trades at prices ranging from $488.90 to $489.89. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":5141,"source":{"system":"sec-edgar","filing":"0001673232-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000004/primarydocument.xml","form_type":"4"}},{"id":945070,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-07T21:31:02.000Z","date":"2026-01-05","kind":"sale","planned":true,"acquired":false,"shares":1189,"price":488.3763,"value":580679.4207,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"This transaction was executed in multiple trades at prices ranging from $487.90 to $488.89. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":5818,"source":{"system":"sec-edgar","filing":"0001673232-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000004/primarydocument.xml","form_type":"4"}},{"id":945069,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-07T21:31:02.000Z","date":"2026-01-05","kind":"sale","planned":true,"acquired":false,"shares":856,"price":487.4037,"value":417217.5672,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This transaction was executed in multiple trades at prices ranging from $486.79 to $487.78. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":7007,"source":{"system":"sec-edgar","filing":"0001673232-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000004/primarydocument.xml","form_type":"4"}},{"id":945068,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-07T21:31:02.000Z","date":"2026-01-05","kind":"sale","planned":true,"acquired":false,"shares":1669,"price":486.05,"value":811217.45,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $485.58 to $486.49. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":7863,"source":{"system":"sec-edgar","filing":"0001673232-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000004/primarydocument.xml","form_type":"4"}},{"id":945067,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-07T21:31:02.000Z","date":"2026-01-05","kind":"sale","planned":true,"acquired":false,"shares":1169,"price":484.995,"value":566959.155,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $484.54 to $485.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":9532,"source":{"system":"sec-edgar","filing":"0001673232-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000004/primarydocument.xml","form_type":"4"}},{"id":945066,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-07T21:31:02.000Z","date":"2026-01-05","kind":"sale","planned":true,"acquired":false,"shares":697,"price":483.8044,"value":337211.6668,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $483.47 to $484.32. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":10701,"source":{"system":"sec-edgar","filing":"0001673232-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000004/primarydocument.xml","form_type":"4"}},{"id":945065,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-07T21:31:02.000Z","date":"2026-01-05","kind":"sale","planned":true,"acquired":false,"shares":873,"price":482.7188,"value":421413.5124,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $482.34 to $483.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":11398,"source":{"system":"sec-edgar","filing":"0001673232-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000004/primarydocument.xml","form_type":"4"}},{"id":945064,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-07T21:31:02.000Z","date":"2026-01-05","kind":"sale","planned":true,"acquired":false,"shares":1657,"price":481.8627,"value":798446.4939,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $481.32 to $482.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":12271,"source":{"system":"sec-edgar","filing":"0001673232-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000004/primarydocument.xml","form_type":"4"}},{"id":945063,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-07T21:31:02.000Z","date":"2026-01-05","kind":"sale","planned":true,"acquired":false,"shares":697,"price":480.6821,"value":335035.4237,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $480.32 to $481.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":13928,"source":{"system":"sec-edgar","filing":"0001673232-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000004/primarydocument.xml","form_type":"4"}},{"id":945062,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-07T21:31:02.000Z","date":"2026-01-05","kind":"exercise","planned":true,"acquired":true,"shares":14625,"price":117.76,"value":1722240.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have\nshared investment and voting power."}],"balance_after":14625,"source":{"system":"sec-edgar","filing":"0001673232-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000004/primarydocument.xml","form_type":"4"}},{"id":945061,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Stock Options","published_at":"2026-01-07T21:30:37.000Z","date":"2026-01-05","kind":"exercise","planned":true,"acquired":false,"shares":7875,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F16","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power."}],"balance_after":52315,"derivative":{"exercise_price":146.03,"exercise_date":"2020-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":7875},"source":{"system":"sec-edgar","filing":"0001673232-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000003/primarydocument.xml","form_type":"4"}},{"id":945060,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-07T21:30:37.000Z","date":"2026-01-05","kind":"sale","planned":true,"acquired":false,"shares":429,"price":494.2724,"value":212042.8596,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F16","text":"Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $480.32 to $481.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001673232-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000003/primarydocument.xml","form_type":"4"}},{"id":945059,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-07T21:30:37.000Z","date":"2026-01-05","kind":"sale","planned":true,"acquired":false,"shares":201,"price":493.4732,"value":99188.1132,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F15","text":"This transaction was executed in multiple trades at prices ranging from $493.99 to $494.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $480.32 to $481.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":429,"source":{"system":"sec-edgar","filing":"0001673232-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000003/primarydocument.xml","form_type":"4"}},{"id":945058,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-07T21:30:37.000Z","date":"2026-01-05","kind":"sale","planned":true,"acquired":false,"shares":598,"price":492.4445,"value":294481.811,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F14","text":"This transaction was executed in multiple trades at prices ranging from $492.96 to $493.88. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $480.32 to $481.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":630,"source":{"system":"sec-edgar","filing":"0001673232-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000003/primarydocument.xml","form_type":"4"}},{"id":945057,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":47432,"kind":"person","name":"BENKOWITZ MICHAEL","position":1,"cik":"0001673232","reported_name":"BENKOWITZ MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-07T21:30:37.000Z","date":"2026-01-05","kind":"sale","planned":true,"acquired":false,"shares":647,"price":491.3496,"value":317903.1912,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"This transaction was executed in multiple trades at prices ranging from $491.91 to $492.86. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $480.32 to $481.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":1228,"source":{"system":"sec-edgar","filing":"0001673232-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000167323226000003/primarydocument.xml","form_type":"4"}}],"next_cursor":"2026-01-07T21:30:37.000000Z,945057"}